Jon Faiz Kayyem - Director at Inhibrx Biosciences, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Issuer Symbol: INBX on Nasdaq
All Insider Reports: All Insider Reports

There are no Buy or Sell transactions made by Jon Faiz Kayyem since 24 May 2025

Holdings reported by Jon Faiz Kayyem for Inhibrx Biosciences, Inc.

Form 4 holding Director

Inhibrx Biosciences, Inc.

Security class: Common Stock
Shares / value: 419,360
Estimated value: $5,951,599
Report date: 27 Mar 2025
Price: $14.19
Ownership: By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust

Form 4 holding Director

Inhibrx Biosciences, Inc.

Security class: Common Stock
Shares / value: 250,000
Estimated value: $3,548,025
Report date: 27 Mar 2025
Price: $14.19
Ownership: By Jon Faiz Kayyem Revocable Trust

Form 4 holding Director

Inhibrx Biosciences, Inc.

Security class: Common Stock
Shares / value: 250,000
Estimated value: $3,548,025
Report date: 27 Mar 2025
Price: $14.19
Ownership: By Paige Gates-Kayyem Revocable Trust

Form 4 holding Director

Inhibrx Biosciences, Inc.

Security class: Common Stock
Shares / value: 69,843
Estimated value: $991,219
Report date: 27 Mar 2025
Price: $14.19
Ownership: By Child A

Form 4 holding Director

Inhibrx Biosciences, Inc.

Security class: Common Stock
Shares / value: 69,843
Estimated value: $991,219
Report date: 27 Mar 2025
Price: $14.19
Ownership: By Child B

Form 4 holding Director

Inhibrx Biosciences, Inc.

Security class: Stock Option (right to buy)
Shares / value: 15,000
Estimated value
Report date: 28 May 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transactions reported by Jon Faiz Kayyem for Inhibrx Biosciences, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .